Ergot alkaloids inhibit 3H-naloxone binding to opiate receptors in the rat striatum and hippocampus
Jazyk angličtina Země Česko Médium print
Typ dokumentu časopisecké články
PubMed
3020603
Knihovny.cz E-zdroje
- MeSH
- corpus striatum účinky léků metabolismus MeSH
- ergoliny farmakologie MeSH
- hipokampus účinky léků metabolismus MeSH
- kinetika MeSH
- krysa rodu Rattus MeSH
- lisurid farmakologie MeSH
- naloxon metabolismus MeSH
- námelové alkaloidy farmakologie MeSH
- receptory opiátové mu MeSH
- receptory opiátové účinky léků metabolismus MeSH
- zvířata MeSH
- Check Tag
- krysa rodu Rattus MeSH
- mužské pohlaví MeSH
- zvířata MeSH
- Publikační typ
- časopisecké články MeSH
- Názvy látek
- ergoliny MeSH
- ergotoxine MeSH Prohlížeč
- lisurid MeSH
- naloxon MeSH
- námelové alkaloidy MeSH
- receptory opiátové mu MeSH
- receptory opiátové MeSH
The authors tested direct effect of selected ergot alkaloids (lisuride, terguride, DH-ergotoxine, DH-ergotamine and DH-ergocristine) on specific 3H-naloxone binding in the rat striatum and hippocampus. In the striatum they found that DH-ergotoxine (a substance with high affinity for noradrenergic receptors) inhibited specific 3H-naloxone binding much more strongly than lisuride and terguride (substances with a greater affinity for dopaminergic and serotoninergic receptors). DH-ergotoxine, which inhibited binding significantly more in the striatum than in the hippocampus, displayed the greatest activity. The results show differences in the degree of inhibition by the various groups of ergot alkaloids in the striatum. In the case of DH-ergotoxine there was also a difference in the degree of inhibition in the striatum and the hippocampus.